---
category: listing
circular_id: 4cfe6fecca03a94c
date: '2025-10-17'
description: Welcure Drugs & Pharmaceuticals Ltd has allotted 11,23,58,200 bonus equity
  shares in the ratio of 1:10, effective October 17, 2025, following a stock split
  from Rs. 10 to Re. 1 face value.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={9057FA70-A060-4235-938A-4813D7A07E1D}&noticeno=20251017-59&dt=10/17/2025&icount=59&totcount=59&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Corporate action affecting shareholding pattern and share capital structure;
  medium impact as it's a bonus issue combined with stock split for a single company
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251017-59&attachedId=9c9d8995-7973-4275-adf5-2ba3e4f5926a
processing:
  attempts: 1
  content_hash: 20803271b2296a55
  processed_at: '2025-10-17T15:23:57.142607'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-10-17T14:51:20+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={9057FA70-A060-4235-938A-4813D7A07E1D}&noticeno=20251017-59&dt=10/17/2025&icount=59&totcount=59&flag=0
severity: medium
source: bse
stocks:
- WELCURE
tags:
- bonus-issue
- stock-split
- corporate-action
- equity-shares
- capital-restructuring
title: Bonus Issue of Welcure Drugs & Pharmaceuticals Ltd - 1:10 Bonus Share Allotment
---

## Summary

Welcure Drugs & Pharmaceuticals Limited (Scrip Code: 524661, ISIN: INE331C01025) has completed the allotment of bonus shares in the ratio of 1:10. The company allotted 11,23,58,200 new equity shares of face value Re. 1/- each on October 17, 2025. This bonus issue was preceded by a stock split from Rs. 10 to Re. 1 face value. The paid-up share capital has increased from Rs. 1,12,35,82,000 to Rs. 1,23,59,40,200.

## Key Points

- **Company**: Welcure Drugs & Pharmaceuticals Limited (CIN: L68100DL1996PLC227773)
- **Scrip Code**: 524661
- **ISIN**: INE331C01025
- **Bonus Ratio**: 1:10 (1 bonus share for every 10 existing shares)
- **Number of Bonus Shares Allotted**: 11,23,58,200 equity shares
- **Face Value**: Re. 1/- per share (after stock split from Rs. 10)
- **Issue Price**: Re. 1/-
- **Distinctive Number Range**: 1,12,35,82,001 to 1,23,59,40,200
- **Capital Before Allotment**: 1,12,35,82,000 equity shares of Re. 1/- each
- **Capital After Allotment**: 1,23,59,40,200 equity shares of Re. 1/- each
- **No Reservation or Abeyance**: No bonus shares reserved or kept in abeyance

## Regulatory Changes

No regulatory changes introduced by this circular. This is a corporate action disclosure as per listing requirements.

## Compliance Requirements

- The company has submitted revised Annexure I reflecting the stock split effect
- Initial submission did not account for the share split; corrected from 1,12,35,820 shares to 11,23,58,200 shares
- Face value updated from Rs. 10.00 to Re. 1.00 in the revised submission

## Important Dates

- **Board Approval Date**: August 22, 2025
- **Shareholder Approval Date**: September 27, 2025
- **Allotment Date**: October 17, 2025
- **Effective Listing Date**: October 20, 2025

## Impact Assessment

**Market Impact**: The bonus issue increases the number of outstanding shares by 10%, improving liquidity and making shares more affordable to retail investors post the stock split. The combination of stock split (10:1) and bonus issue (1:10) significantly increases the total share count from the original base.

**Shareholder Impact**: Existing shareholders receive 1 additional share for every 10 shares held. Combined with the stock split, shareholders who originally held 1 share of Rs. 10 face value now hold 11 shares of Re. 1 face value each.

**Company Impact**: The paid-up capital increases by approximately 10% from Rs. 1,12,35,82,000 to Rs. 1,23,59,40,200. This is a capitalization of reserves with no fresh capital infusion. The action may improve stock liquidity and marketability.